Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 870-881

  Liu, Zi Hui ^a   Wang, Ming Hui ^b   Ren, Hong Jiu ^a   Qu, Wei ^a   Sun, Li Mei ^a   Zhang, Qing Fu ^a   Qiu, Xue Shan ^a   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CHENGDE MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Interleukin 7; Interleukin 7 receptor; NSCLC; P53

Indexed keywords

IL7 PROTEIN, HUMAN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TP53 PROTEIN, HUMAN;

APOPTOSIS; FLOW CYTOMETRY; HUMAN; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-7; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899578242     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kibe R, Zhang S, Guo D, Marrero L, Tsien F, Rodriguez P, Khan S, Zieske A, Huang J, Li W, Durum SK, Iwakuma T, Cui Y. IL-7Ra deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death Differ 2012; 19: 1139-51.
2. Sammicheli S, Dang VP, Ruffin N, Pham HT, Lantto R, Vivar N, Chiodi F, Rethi B. IL-7 Promotes CD95-Induced Apoptosis in B Cells via the IFN-γ/STAT1 Pathway. PLoS One 2011; 12: e28629.
3. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 2004; 22: 625-55.
4. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20: 394-7.
5. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180: 1955-60.
6. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 10: 749-58.
7. Ming J, Zhang Q, Qiu X, Wang E. Interleukin 7/Interleukin 7 Receptor Induce c-Fos/c-Jun-Dependent Vascular Endothelial Growth Factor-D Up-Regulation: A Mechanism of Lymphangiogenesis in Lung Cancer. Eur J Cancer 2009; 45: 866-73.
8. Ming J, Guo C, Zhang Q, Qiu X, Wang E. Interleukin 7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother 2012; 61: 79-88.
9. Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999; 59: 1693-1700.
10. Reed JC. Double identity for protections of the Bcl-2 family. Nature 1997; 387: 773-6.
11. Yang E and Korsmeyer SJ. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 1996; 2: 386-401.
12. Gibson LF, Piktel D, Narayanan R, Nuñez G, Landreth KS. Stromal cells regulate bcl-2 and bax expression in pro-B cells. Exp Hematol 1996; 24: 628-37.
13. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-10.
14. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996; 26: 294-9.
15. Wörnle M, Schmid H, Merkle M, Banas B. Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 2004; 5: 8.
16. Wu S, Xing W, Peng J, Yuan X, Zhao X, Lei P, Li W, Wang M, Zhu H, Huang B, Huang L, Shen G. Tumor transfected with CCL21 enhanced reactivity and apoptosis resistance of human monocytederived dendritic cells. Immunobiology 2008; 213: 417-26.
17. Burmakin M, Shi Y, Hedstrom E, Kogner P, Selivanova G. Dual targeting of wild type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro. Clin Cancer Res 2013; 19: 5092-103.
18. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 30: 1010-14.
19. Gwinn MR, Leonard SS, Sargent LM, Lowry DT, McKinstry K, Meighan T, Reynolds SH, Kashon M, Castranova V, Vallyathan V. The role of p53 in silica-induced cellular and molecular responses associated with carcinogenesis. J Toxicol Environ Health 2009; 23: 1509-19.
20. + effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 2010; 3: 418-26.
21. Corfe SA, Paige CJ. The many roles of IL-7 in B cell development; Mediator of survival, proliferation and differentiation. Semin Immunol 2012; 24: 198-208.
22. Shalapour S, Deiser K, Kühl AA, Glauben R, Krug SM, Fischer A, Sercan O, Chappaz S, Bereswill S, Heimesaat MM, Loddenkemper C, Fromm M, Finke D, Hämmerling GJ, Arnold B, Siegmund B, Schüler T. Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis. PLoS One 2012; 2: e31939.
23. ElKassar N, Gress RE. An Overview of IL-7 Biology and Its Use in Immunotherapy. J Immunotoxicol 2010; 1: 1-7.
24. Rusconi S, Vitiello P, Adorni F, Colella E, Focà E, Capetti A, Meraviglia P, Abeli C, Bonora S, D'Annunzio M, Di Biagio A, Di Pietro M, Butini L, Orofino G, Colafigli M, d'Ettorre G, Francisci D, Parruti G, Soria A, Buonomini AR, Tommasi C, Mosti S, Bai F, Di Nardo Stuppino S, Morosi M, Montano M, Tau P, Merlini E, Marchetti G. Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial. PLoS One 2013; 11: e80157.
25. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198: 1797-806.
26. Ostiguy V, Allard EL, Marquis M, Leignadier J, Labrecque N. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J Leukoc Biol 2007; 82: 645-56.
27. Jiang Q, Li WQ, Hofmeister RR, Young HA, Hodge DR, Keller JR, Khaled AR, Durum SK. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol 2004; 24: 6501-13.
28. Lu L, Chaudhury P, Osmond DG. Regulation of Cell Survival During B Lymphopoiesis: Apoptosis and Bcl-2/Bax Content of Precursor B Cells in Bone Marrow of Mice with Altered Expres sion of IL-7 and Recombinase-Activating Gene-2. J Immunol 1999; 162: 1931-40.
29. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89: 1033.
30. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. BCL2 can rescue T lymphocyte development in IL-7 receptor deficient mice but not in mutant RAG-/-mice. Cell 1997; 89: 1011.
31. Kim K, Khaled AR, Reynolds D, Young HA, Lee CK, Durum SK. Characterization of an interleukin-7-dependent thymic cell line derived from a p53-/-mouse. J Immunol Methods 2003; 274: 177-84.
32. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. The Trophic Action of IL-7 on Pro-T Cells: Inhibition of Apoptosis of Pro-T1,-T2, and-T3 Cells Correlates with Bcl-2 and Bax Levels and Is Independent of Fas and p53 Pathways. J Immunol 1998; 160: 5735-41.
33. + T Cells: IL-2 and IL-7 Differentially Regulate the Balance Between Proliferation and Fas-Mediated Apoptosis. J Immunol 2003; 171: 61-8.
34. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189-200.